• Latest
  • Trending
The Pink Pill: Sex, Drugs & Who Has Control Review

The Pink Pill: Sex, Drugs & Who Has Control Review: Who Decides Which Desire Matters?

Who Is Martin Mull? Review

Who Is Martin Mull? Review: What the Paintings Remember

In This Darkness I See You Review

In This Darkness I See You Review: Whispering Walls and Unfinished Human Connections

Blueberry Review

Blueberry Review: The Colors of Distress, the Limits of a Meter

The Matriarch Review

The Matriarch Review: Mother Knows How to Keep Control

The Altruists Review

The Altruists Review: When Generosity Becomes an Alibi

Children of the Sun Review

Children of the Sun Review: The Awkward Kisses Say It Best

Dead Drop Review

Dead Drop Review: Big Trouble in a Very Small Box

Kioku: Last Summer Review

Kioku: Last Summer Review: Collecting Monsters Beats Battling Them

No Me Without You Review

No Me Without You Review: Sisterhood Between Glass and Greenery

The Law of Beasts Review

The Law of Beasts Review: Two Friends and the Cost of a Promised Outcome

Ethos Season 2 Review

Ethos Season 2 Review: Four Episodes and No Safe Place to Speak

Zombucha! Review

Zombucha! Review: Wellness for Sale, Responsibility Optional

  • Home
  • Privacy Policy
  • Terms and Conditions
  • Gazettely Review Guidelines
Friday, November 20, 2026
GAZETTELY
  • Home
  • Movie and TV News
    The Hunt for Gollum

    Jamie Dornan Feels “Pressure” Replacing Viggo Mortensen in “The Hunt for Gollum”

    Call Me by Your Name

    Timothée Chalamet on “Call Me by Your Name” Sequel: “Never Say Never,” but Reluctant

    Physical Asia

    Netflix Renews “Physical: Asia” for Season 2, Set for 2027

    Taylor Swift

    Taylor Swift Returns to CMA Awards After 13 Years, Weaves “Our Song” Into “Toy Story 5” Single

    Robert Pattinson

    Robert Pattinson Toured Rikers Island in Disguise Before “Good Time,” and an Inmate Saw Through It

    Cher

    Christina Ricci Says Cher Hasn’t Spoken to Her in Decades Over Unreturned Voicemail

    Confession

    Rob Lowe Says He Asked Ben Shapiro for Role in “Confession”

    Chris Pratt 1

    Chris Pratt to Star in Paramount’s “The Traveler” Under New Producing Deal

    Grand Theft Auto Movie

    Take-Two CEO Won’t Rule Out a Grand Theft Auto Movie, but Stays “Very, Very Selective”

  • Movie and TV Reviews
    Who Is Martin Mull? Review

    Who Is Martin Mull? Review: What the Paintings Remember

    In This Darkness I See You Review

    In This Darkness I See You Review: Whispering Walls and Unfinished Human Connections

    The Matriarch Review

    The Matriarch Review: Mother Knows How to Keep Control

    The Altruists Review

    The Altruists Review: When Generosity Becomes an Alibi

    Children of the Sun Review

    Children of the Sun Review: The Awkward Kisses Say It Best

    Dead Drop Review

    Dead Drop Review: Big Trouble in a Very Small Box

    No Me Without You Review

    No Me Without You Review: Sisterhood Between Glass and Greenery

    The Law of Beasts Review

    The Law of Beasts Review: Two Friends and the Cost of a Promised Outcome

    Ethos Season 2 Review

    Ethos Season 2 Review: Four Episodes and No Safe Place to Speak

  • Game Reviews
    Blueberry Review

    Blueberry Review: The Colors of Distress, the Limits of a Meter

    Kioku: Last Summer Review

    Kioku: Last Summer Review: Collecting Monsters Beats Battling Them

    Ranger’s Path: National Park Simulator Review

    Ranger’s Path: National Park Simulator Review: A Wider Role With Familiar Chores

    The Relic: First Guardian Review

    The Relic: First Guardian Review: Folklore Caught in a Failing World

    Grand Theft Auto VI Review

    Grand Theft Auto VI Review: Getting Paid Is Only Half the Job

    Farming Simulator 26 Review

    Farming Simulator 26 Review: Plenty to Farm, Less to Customize

    Wardrum Review

    Wardrum Review: Seven Boars and a Beat You Know by Heart

    Akuma Rise Review

    Akuma Rise Review: Useful Debuffs and Uneven Attachments

    Milki Delivery Review

    Milki Delivery Review: Building Belonging One Bottle at a Time

  • The Bests
No Result
View All Result
  • Home
  • Movie and TV News
    The Hunt for Gollum

    Jamie Dornan Feels “Pressure” Replacing Viggo Mortensen in “The Hunt for Gollum”

    Call Me by Your Name

    Timothée Chalamet on “Call Me by Your Name” Sequel: “Never Say Never,” but Reluctant

    Physical Asia

    Netflix Renews “Physical: Asia” for Season 2, Set for 2027

    Taylor Swift

    Taylor Swift Returns to CMA Awards After 13 Years, Weaves “Our Song” Into “Toy Story 5” Single

    Robert Pattinson

    Robert Pattinson Toured Rikers Island in Disguise Before “Good Time,” and an Inmate Saw Through It

    Cher

    Christina Ricci Says Cher Hasn’t Spoken to Her in Decades Over Unreturned Voicemail

    Confession

    Rob Lowe Says He Asked Ben Shapiro for Role in “Confession”

    Chris Pratt 1

    Chris Pratt to Star in Paramount’s “The Traveler” Under New Producing Deal

    Grand Theft Auto Movie

    Take-Two CEO Won’t Rule Out a Grand Theft Auto Movie, but Stays “Very, Very Selective”

  • Movie and TV Reviews
    Who Is Martin Mull? Review

    Who Is Martin Mull? Review: What the Paintings Remember

    In This Darkness I See You Review

    In This Darkness I See You Review: Whispering Walls and Unfinished Human Connections

    The Matriarch Review

    The Matriarch Review: Mother Knows How to Keep Control

    The Altruists Review

    The Altruists Review: When Generosity Becomes an Alibi

    Children of the Sun Review

    Children of the Sun Review: The Awkward Kisses Say It Best

    Dead Drop Review

    Dead Drop Review: Big Trouble in a Very Small Box

    No Me Without You Review

    No Me Without You Review: Sisterhood Between Glass and Greenery

    The Law of Beasts Review

    The Law of Beasts Review: Two Friends and the Cost of a Promised Outcome

    Ethos Season 2 Review

    Ethos Season 2 Review: Four Episodes and No Safe Place to Speak

  • Game Reviews
    Blueberry Review

    Blueberry Review: The Colors of Distress, the Limits of a Meter

    Kioku: Last Summer Review

    Kioku: Last Summer Review: Collecting Monsters Beats Battling Them

    Ranger’s Path: National Park Simulator Review

    Ranger’s Path: National Park Simulator Review: A Wider Role With Familiar Chores

    The Relic: First Guardian Review

    The Relic: First Guardian Review: Folklore Caught in a Failing World

    Grand Theft Auto VI Review

    Grand Theft Auto VI Review: Getting Paid Is Only Half the Job

    Farming Simulator 26 Review

    Farming Simulator 26 Review: Plenty to Farm, Less to Customize

    Wardrum Review

    Wardrum Review: Seven Boars and a Beat You Know by Heart

    Akuma Rise Review

    Akuma Rise Review: Useful Debuffs and Uneven Attachments

    Milki Delivery Review

    Milki Delivery Review: Building Belonging One Bottle at a Time

  • The Bests
No Result
View All Result
GAZETTELY
No Result
View All Result
The Pink Pill: Sex, Drugs & Who Has Control Review

Fukushima: A Nuclear Nightmare Review: Japan's Safety Myth Explodes

Harry Styles: One Night in Manchester Review: The Dancefloor Suits Him

Home Entertainment Movies

The Pink Pill: Sex, Drugs & Who Has Control Review: Who Decides Which Desire Matters?

Marcus Thorne by Marcus Thorne
5 months ago
in Entertainment, Movies, Reviews
Reading Time: 5 mins read
A A
0
Share on FacebookShare on TwitterShare on PinterestShare on WhatsAppShare on TelegramSummarize with ChatGPTSummarize with Perplexity

A regulator wondering aloud if a woman might take flibanserin at night and fall asleep while driving her children to school reveals plenty before the pharmacology has finished speaking. The hypothetical, recalled by psychiatrist Dr. Anita Clayton, places motherhood inside the FDA’s risk calculation and female pleasure somewhere beyond the frame. Aisling Chin-Yee understands the implication. The Pink Pill: Sex, Drugs & Who Has Control spends much of its running time examining who gets lit as a patient and who remains a complication.

The documentary traces the history of flibanserin, sold as Addyi, a treatment for Hypoactive Sexual Desire Disorder. Developed first as an antidepressant, the drug showed an effect on female libido through its interaction with neurotransmitters.

Barbara Gattuso, whose desire had disappeared during her perimenopausal years, appears in clinical-trial footage from 2010 almost startled by her own return. She talks about chasing her husband again. The woman on camera is giddy. The archive needs no dramatic reenactment.

Chin-Yee places this beside the swift cultural acceptance of Viagra in 1998. Male erectile dysfunction became a medical problem worthy of chemistry. Women describing absent desire heard suggestions involving wine, baths, rest, and fewer children underfoot. Medicine, it seems, can be remarkably sophisticated until someone asks it to take female pleasure seriously.

The Pink-Clad Protagonist

Cindy Eckert enters the film dressed in the color scheme of her argument. Pink clothes. Pink offices. Pink branding. Subtlety has missed its appointment. After Boehringer Ingelheim abandoned its effort to win FDA approval for flibanserin,

Eckert bought the drug for $5 million in 2011 and pursued approval through Sprout Pharmaceuticals. Chin-Yee frames her as the primary moving force in the story, and the documentary’s visual grammar follows suit. Interviews, campaign footage, and FDA material repeatedly return to Eckert as the face moving against institutional resistance.

The resistance offers strong material. Addyi works on brain chemistry, yet its review landed in the FDA’s urology division, a bureaucratic placement shaped around the physical mechanism of drugs such as Viagra. Regulators focused on dizziness, nausea, fatigue, low blood pressure, and sedation.

They also questioned efficacy, treating an increase of roughly one successful sexual event per month as negligible. The film answers with the experience of untreated women who might record one or two such events across an entire year.

Chin-Yee is less patient with the counterargument that HSDD risks medicalizing natural changes in desire. Critics ask who defines a normal libido and who profits once that definition acquires a prescription pad. Those are serious questions, especially inside the American pharmaceutical system. The camera hears them, then returns quickly to Eckert.

There is a problem of exposure here. Eckert sold Sprout to Valeant for $1 billion after Addyi’s 2015 approval. That fact changes the moral lighting of her story, or should. Her later effort to regain the drug after Valeant raised its price to around $800 per prescription and shelved it complicates the image again. Chin-Yee prefers the bright key light of feminist advocacy when a little chiaroscuro would have served her subject better.

The Women the Debate Keeps Losing

The documentary becomes harder to dismiss when Barbara Gattuso and other women speak without the pharmaceutical vocabulary surrounding them. One woman explains that she assumed desire simply disappeared after childbirth. Another describes menopause destroying a previously steady libido and leaving her emotionally hollow. These testimonies shift the argument from sexual frequency to absence.

The Pink Pill: Sex, Drugs & Who Has Control Review

Gattuso and her daughter appear at the FDA’s public hearing, speaking about the strain her vanished desire placed on her marriage and sense of self. Opponents respond with suggestions involving chocolate, pornography, Fifty Shades of Grey, a removable shower head, and switching boyfriends.

Jimmy Fallon jokes that flibanserin’s previous name was wine. The editing does something useful by allowing those remarks to accumulate. One joke is trivial. Several become a pattern. The film’s darkest corridor is built from laughter.

Addyi eventually receives approval with a black box warning. Doctors must complete certification before prescribing it. Pharmacists face their own requirement. Women taking the drug are told to pledge against alcohol consumption.

Chin-Yee cuts this regulatory severity against the comparatively casual guidance surrounding Viagra and alcohol. The juxtaposition is persuasive because it is concrete. It does not require the documentary to announce sexism every thirty seconds, though the documentary occasionally does something close to that anyway.

The Missing Science in the Room

Chin-Yee’s strongest directorial choice is her use of institutional archive. FDA hearings, clinical-trial recordings, television jokes, and advocacy footage create a record of how female sexual desire moved from private distress to public argument. The Peaches track blasting through the opening announces the film’s attitude before the first expert finishes a sentence. This is advocacy with a soundtrack.

That confidence becomes a liability when the film reaches the science of HSDD. Doctors explain the difference between reproductive health and sexual health. Medical professionals admit that their training offered almost nothing on female libido or clitoral anatomy.

Yet the documentary spends surprisingly little time showing how HSDD is clinically diagnosed, how trial outcomes were measured beyond successful sexual events, or why flibanserin’s neurological effects support the claims Eckert makes.

The omission leaves a strange patch of darkness in a film arguing that female sexual medicine deserves serious scientific attention. Chin-Yee can show the FDA asking the wrong questions. She is less rigorous about showing viewers the full set of right ones.

The final political expansion reaches toward the reversal of Roe v. Wade, reproductive restrictions, and attacks on trans healthcare. The connection is clear: bodily autonomy depends heavily on institutions deciding which choices remain available. Yet these subjects arrive late, widening the frame after the Addyi story has occupied most of the picture.

The women describing vanished desire remain the documentary’s sharpest evidence. Their words survive the corporate branding, the FDA bureaucracy, and the film’s occasional impatience with ambiguity. One woman says menopause left her feeling as if someone had slayed her. Chin-Yee holds the testimony long enough for the room to go quiet.

The provocative documentary premiered on March 6, 2026, and is available to stream on Paramount+. The film chronicles the fierce, decade-long battle led by women’s health advocates and entrepreneurs to secure regulatory approval for the first female libido enhancement drug, highlighting deep-seated gender disparities within medical research and institutional health care.

Where to Watch The Pink Pill: Sex Drugs & Who Has Control (2025) Online

Paramount+ Amazon Channel
4k
Paramount+ Amazon Channel
Flat
Paramount+ Roku Premium Channel
hd
Paramount+ Roku Premium Channel
Flat
Paramount Plus Premium
4k
Paramount Plus Premium
Flat
Paramount Plus Essential
hd
Paramount Plus Essential
Flat
Source: JustWatch

Full Credits

  • Title: The Pink Pill: Sex, Drugs & Who Has Control

  • Distributor: Paramount+

  • Release date: March 6, 2026

  • Running time: 1 hour 28 minutes

  • Director: Aisling Chin-Yee

  • Writers: Aisling Chin-Yee, Steve Taylor

  • Producers and Executive Producers: Julie Bristow, Abby Greensfelder, Vibika Bianchi, Joanna Griffiths, Aisling Chin-Yee

  • Cast: Cindy Eckert, Josephine Torrente, Irwin Goldstein

  • Director of Photography (Cinematographer): Nina Djacic

  • Editors: Steve Taylor

The Review

The Pink Pill: Sex, Drugs & Who Has Control

7 Score

The Pink Pill: Sex, Drugs & Who Has Control points its harshest light at the institutions deciding which forms of suffering deserve treatment. Aisling Chin-Yee builds a persuasive case from FDA hearings, Barbara Gattuso's testimony, and the restrictions placed on Addyi, though the film leaves too much of the drug's clinical science in shadow. Cindy Eckert's dominance also gives several passages the gloss of advocacy. Still, the women describing vanished desire cut through every corporate and political frame. The system debates risk. They describe absence.

PROS

  • Powerful patient testimony
  • Sharp examination of medical bias
  • Strong FDA hearing material
  • Clear political urgency

CONS

  • Thin clinical detail
  • Eckert dominates the framing
  • Advocacy sometimes overtakes inquiry
  • Late political expansion feels compressed

Review Breakdown

  • Overall 0
Tags: A Serbian DocumentaryAisling Chin-YeeCindy EckertFeaturedIrwin GoldsteinJosephine TorrenteParamount+The Pink Pill: Sex Drugs & Who Has Control
Previous Post

Fukushima: A Nuclear Nightmare Review: Japan’s Safety Myth Explodes

Next Post

Harry Styles: One Night in Manchester Review: The Dancefloor Suits Him

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Oldest
Newest Most Voted

This Week's Top Reads

  • Is This Seat Taken? Review

    Is This Seat Taken? Review: A Satisfying Mental Workout

    1263 shares
    Share 0 Tweet 0
  • Confession Review: Faith Holds Firm While the Drama Stalls

    0 shares
    Share 0 Tweet 0
  • The Good Daughter Review: Fahy and Byrne Make Family Friction Worth Watching

    0 shares
    Share 0 Tweet 0
  • Hunting Alice Bell Review: Five Women and the Price of Being Heard

    0 shares
    Share 0 Tweet 0
  • Shetland Season 11 Review: Good Detective Work Meets a Dubious Descent

    1 shares
    Share 0 Tweet 0
  • Anaesthesia Review: A Gifted Surgeon Faces Uneven Scrutiny

    0 shares
    Share 0 Tweet 0
  • “The Body” Creators Explain That Ending and Say They Have Several Seasons Planned

    0 shares
    Share 0 Tweet 0

Must Read Articles

The Altruists Review
TV Shows

The Altruists Review: When Generosity Becomes an Alibi

1 day ago
Ethos Season 2 Review
TV Shows

Ethos Season 2 Review: Four Episodes and No Safe Place to Speak

1 day ago
Percy Jackson and the Olympians Season 3 Review
TV Shows

Percy Jackson and the Olympians Season 3 Review: Growing Pains on Olympus

1 day ago
Guarding Stars Review
Movies

Guarding Stars Review: Leighton Meester Takes Charge of a Charming Christmas Romance

1 day ago
The Chosen Season 6 Review
TV Shows

The Chosen Season 6 Review: The Power to Let It Happen

2 days ago

Gazettely is your go-to destination for all things gaming, movies, and TV. With fresh reviews, trending articles, and editor picks, we help you stay informed and entertained.

© 2021-2026 All Rights Reserved for Gazettely

What’s Inside

  • Movie & TV Reviews
  • Game Reviews
  • Featured Articles
  • Latest News
  • Editorial Picks

Quick Links

  • Home
  • About US
  • Contact Us
  • Advertise with Us
  • Review Guidelines

Follow Us

Facebook X-twitter Youtube Instagram
No Result
View All Result
  • Gazettely | Movie, TV & Game Reviews, News, and Rankings
  • Movies
  • Entertainment News
  • Movie and TV Reviews
  • TV Shows
  • Game News
  • Game Reviews
  • Contact Us

© 2024 All Rights Reserved for Gazettely

wpDiscuz
0
0
Would love your thoughts, please comment.x